Journal
DIABETES
Volume 71, Issue 7, Pages 1472-1489Publisher
AMER DIABETES ASSOC
DOI: 10.2337/db21-0800
Keywords
-
Categories
Funding
- Wellcome Trust [098424AIA, 212625/Z/18/Z]
- Medical Research Council Programme grants [MR/R022259/1, MR/J0003042/1, MR/L020149/1]
- Experimental Challenge Grant [MR/L02036X/1]
- Medical Research Council [MR/N00275X/1, MR/R010676/1]
- Diabetes UK grants [BDA/11/0004210, BDA/15/0005275, BDA16/0005485]
- Diabetes UKD project grant [16/0005485]
- European Commission Innovative Medicines Initiative 2 Joint Undertaking [115881]
- European Union
- National Institutes of Health [R03 DK115990, R01 DK108921, U01 DK127747]
- Human Islet Research Network [UC4 DK104162, RRID:SCR_014393]
- Academy of Medical Sciences
- Society for Endocrinology
- British Society for Neuroendocrinology
- European Federation for the Study of Diabetes
- Engineering and Physical Sciences Research Council capital award
- JDRF [CDA-2016-189, SRA-2018-539, COE-2019-861]
- U.S. Department of Veterans Affairs [I01 BX004444]
Ask authors/readers for more resources
Mitofusin gene expression is essential for maintaining normal glucose metabolism in pancreatic beta-cells, but does not affect incretin signaling. These findings are important for understanding the roles of mitofusins in beta-cells, the potential contributions of altered mitochondrial dynamics to diabetes development, and the impact of incretins on this process.
Mitochondrial glucose metabolism is essential for stimulated insulin release from pancreatic beta-cells. Whether mitofusin gene expression, and hence, mitochondrial network integrity, is important for glucose or incretin signaling has not previously been explored. Here, we generated mice with beta-cell-selective, adult-restricted deletion knock-out (dKO) of the mitofusin genes Mfn1 and Mfn2 (beta Mfn1/2 dKO). beta Mfn1/2-dKO mice displayed elevated fed and fasted glycemia and a more than fivefold decrease in plasma insulin. Mitochondrial length, glucose-induced polarization, ATP synthesis, and cytosolic and mitochondrial Ca2+ increases were all reduced in dKO islets. In contrast, oral glucose tolerance was more modestly affected in beta Mfn1/2-dKO mice, and glucagon-like peptide 1 or glucose-dependent insulinotropic peptide receptor agonists largely corrected defective glucose-stimulated insulin secretion through enhanced EPAC-dependent signaling. Correspondingly, cAMP increases in the cytosol, as measured with an Epac-camps-based sensor, were exaggerated in dKO mice. Mitochondrial fusion and fission cycles are thus essential in the beta-cell to maintain normal glucose, but not incretin, sensing. These findings broaden our understanding of the roles of mitofusins in beta-cells, the potential contributions of altered mitochondrial dynamics to diabetes development, and the impact of incretins on this process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available